FOXA1 and cancer: In total, 41 and 65 differentially enriched genes were identified from CUT&Tag and ChIP-seq data, respectively, with only FOXA1 and IER2 appearing in both datasets (Fig. 4P), highlighting FOXA1 as a conserved, cancer-specific SE target.